Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- University of Bergen
- ; University of Birmingham
- Amsterdam UMC
- Amsterdam UMC; Amsterdam
- Canadian Association for Neuroscience
- Duke University
- Leiden University
- Leiden University; Leiden
- Maastricht University (UM)
- Maastricht University (UM); yesterday published
- Newcastle University;
- The University of Iowa
- University of Newcastle
- University of Southern Denmark
- 4 more »
- « less
-
Field
-
magnetic stimulation (TMS) for personalized epilepsy treatments! PhD Candidate: Towards Personalized Brain Stimulation for Epilepsy Treatment Our goal: To improve the lives of people with epilepsy by
-
Welcome to Maastricht University! Join us in optimizing transcranial magnetic stimulation (TMS) for personalized epilepsy treatments! PhD Candidate: Towards Personalized Brain Stimulation
-
will do What you will do Your research will extend our work on smartphone interactions to people with epilepsy, investigating how significant life events—such as seizures or daily stressors—are reflected
-
health by analyzing everyday behavioral patterns. What you will do What you will do Your research will extend our work on smartphone interactions to people with epilepsy, investigating how significant life
-
mission: to uncover how nutrient signaling pathways, particularly GATOR1-mTORC1, influence neurodevelopment and seizure formation in epilepsy and autism. Why Join Us? Work on cutting-edge projects exploring
-
new brain stimulation methods, you will contribute to developing closed-loop algorithms for regulating brain dynamics with clinical applications in epilepsy and psychiatric disorders. Number of awards
-
the potential risks ASMs may pose to unborn children. ASMs are widely prescribed for epilepsy, bipolar disorder, pain, and other neurological and psychiatric conditions. While some ASMs are known to increase
-
for epilepsy, bipolar disorder, pain, and other neurological and psychiatric conditions. While some ASMs are known to increase the risk of birth defects and neurodevelopmental disorders, most newer ASMs have not
-
in the brain. SNAREopathies are characterized by severe developmental delay, intellectual disability, motor problems and often epilepsy. Currently we have no cure for these patients beyond seizure
-
Dysregulation of the complement system is increasingly recognised as a key driver of neuroinflammation and neurodegeneration in progressive CNS disorders, including multiple sclerosis and epilepsy